{"id":"W2947823476","doi":"10.1200/jco.2019.37.15_suppl.4079","title":"Pembrolizumab (pembro) for advanced biliary adenocarcinoma: Results from the KEYNOTE-028 (KN028) and KEYNOTE-158 (KN158) basket studies.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pembrolizumab; Internal medicine; Biliary tract cancer; Clinical endpoint; Oncology; Gastroenterology; Clinical trial; Cancer; Immunotherapy; Gemcitabine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.003360241,0.0003418116,0.002641893,0.0001321421,0.0001387361,0.0000198722,0.0003588633,0.0004382023,0.00004508106],"category_scores_gemma":[0.01008294,0.00020031,0.0008373826,0.0002166833,0.000509428,0.0001827455,0.0002561572,0.001307297,0.00003053052],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000215761,"about_ca_system_score_gemma":0.001340901,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005641416,"about_ca_topic_score_gemma":0.0001104468,"domain_scores_codex":[0.9950286,0.0004390377,0.002963937,0.0005837042,0.0005086218,0.0004760958],"domain_scores_gemma":[0.9803082,0.01591142,0.001888513,0.0006023732,0.000920108,0.0003693952],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1442032,0.001643621,0.5091513,0.0002971205,0.005627995,0.000701272,0.004632774,0.00003714471,0.0007480994,0.0002516216,0.1802847,0.1524212],"study_design_scores_gemma":[0.05468103,0.01673807,0.7695,0.000301278,0.001293711,0.0002713583,0.002470899,0.00009949116,0.00007418456,0.001081987,0.1532364,0.0002516109],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9220807,0.03158494,0.00004706104,0.0396187,0.003680314,0.0008708778,0.00006971908,0.00002101247,0.002026657],"genre_scores_gemma":[0.9786211,0.006556573,0.00276084,0.007207389,0.003310089,0.00001435704,0.0000138258,0.00004291876,0.001472944],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2603486,"threshold_uncertainty_score":0.9982556,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1614750808309898,"score_gpt":0.4601049431994882,"score_spread":0.2986298623684984,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}